Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Genentech to suspend CREAD trials of Alzheimer’s disease drug

PET scan of a healthy brain compared to a brain at an early stage of Alzheimer’s disease. Credit: Institut Douglas.

  • Genentech

Go Top